Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, ...

Earnings Call Insights: Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025 Christophe Weber, CEO, announced his ...

Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. Weber – who was briefly chief operating officer of Takeda ...

Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and representative director, effective from June 2026. The decision was unanimously ...

Takeda will hold an investor vote on its $62 billion acquisition of Shire next month, and aims to close the deal on January 8. Under the leadership of CEO Christophe Weber, Takeda is hoping to ...

Reuters said that Takeda plans to sell up to $10 billion worth of unwanted assets – but Weber reportedly told a news conference that selling off the OTC unit will not be the company’s first ...

Takeda’s CEO has said he is confident that its $62 billion acquisition of Shire will go ahead, despite a rebellion from a dissident group of shareholders. Christophe Weber spoke on the matter at ...

Takeda has announced that its Board of Directors has approved the appointment of Christophe Weber to become its Chief Operating Officer (COO) and candidate for its next Chief Executive Officer (CEO).

That’s Christophe Weber’s time frame for shedding assets as Takeda Pharmaceutical Co tries to reduce a heavy debt load after completing its US$62bil takeover of Shire Plc. NEW YORK: The sooner ...